Provided by Tiger Trade Technology Pte. Ltd.

FOSUN PHARMA

16.880
-0.260-1.52%
Volume:2K
Turnover:25.32K
Market Cap:44.77B
PE:11.37
High:16.880
Open:16.880
Low:16.880
Close:17.140
52wk High:27.920
52wk Low:14.505
Shares:2.65B
HK Float Shares:534.00M
Volume Ratio:- -
T/O Rate:0.00%
Dividend:0.46
Dividend Rate:2.70%
EPS(LYR):1.484
ROE:6.95%
ROA:1.40%
PB:0.79
PE(LYR):11.37
PS:0.90

Loading ...

Fosun Pharma Schedules 28 April Board Meeting to Review Q1 2026 Results

Bulletin Express
·
Apr 10

Fosun Pharmaceutical Names CFO

MT Newswires Live
·
Apr 03

Fosun Pharmaceutical's Subsidiary Gets Nod for Phase I Trial for Breast Cancer Drug

MT Newswires Live
·
Apr 02

FOSUN PHARMA Subsidiary Receives Clinical Trial Approval for HLX319 Drug

Stock News
·
Apr 01

Fosun Pharmaceutical to Set Up Parallel Fund Structure

MT Newswires Live
·
Apr 01

Fosun Pharma Unit Gets China Nod for Tumor Drug Trial

MT Newswires Live
·
Mar 31

Fosun Pharma Subsidiary Secures NMPA Approval to Launch Phase I Trial of FXB0871 for Advanced Solid Tumors

Bulletin Express
·
Mar 31

BRIEF-Shanghai Fosun Pharma Announces Approval From NMPA For Clinical Trial Of FXB0871

Reuters
·
Mar 31

Shanghai Fosun Pharma - Approval From Nmpa for Clinical Trial of Fxb0871

THOMSON REUTERS
·
Mar 31

FOSUN PHARMA Reports 2025 Results: Revenue Hits 41.7B Yuan with 21.7% Net Profit Growth

Deep News
·
Mar 25

FOSUN PHARMA Shares Surge Over 5% as Annual Net Profit Climbs 21.69% to 3.37 Billion Yuan

Deep News
·
Mar 25

Stock Track | Fosun Pharma Soars 5.21% Intraday on Strong 2025 Earnings and Dividend Announcement

Stock Track
·
Mar 25

FOSUN PHARMA Declares Final Dividend of HK$0.39 Per Share

Stock News
·
Mar 25

Fosun Pharma Announces RMB0.39 Final Dividend for FY2025

Bulletin Express
·
Mar 25

Fosun Pharma 2025 Results: Net Profit Up 21.69%, Innovative-Drug Sales Surge 29.59%

Bulletin Express
·
Mar 25

Shanghai Fosun Pharma - Proposed to Distribute Cash Dividend of RMB0.39 for Each Ordinary Share

THOMSON REUTERS
·
Mar 25

Press Release: Fosun Pharma Announces 2025 Annual Results

Dow Jones
·
Mar 24

FOSUN PHARMA Subsidiaries to Expand Financing Through Leasing Agreements

Stock News
·
Mar 24

Fosun Pharma Reports 2025 Results: Dual Engines of Innovative Drugs and Globalization Drive High-Quality Growth

Stock News
·
Mar 24

Fosun Pharma (02196) Subsidiary Obtains NMPA Green Light for Sodium Thiosulfate Injection

Bulletin Express
·
Mar 20